Optipharm.CO.,LTD

A153710

KR7153710009

Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 23:00:00 16/05/2024 BST			5-day change	1st Jan Change
6,860 ^KRW	+0.15%		+2.24%	-2.42%

2023	Optipharm.CO.,LTD Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
2022	Optipharm.CO.,LTD(KOSDAQ:A153710) dropped from S&P Global BMI Index	CI

Optipharm.CO.,LTD(KOSDAQ:A153710) added to S&P Global BMI Index

September 21, 2020 at 05:00 am

Latest news about Optipharm.CO.,LTD

Optipharm.CO.,LTD Reports Earnings Results for the First Quarter Ended March 31, 2023	12/05/23	CI
Optipharm.CO.,LTD(KOSDAQ:A153710) dropped from S&P Global BMI Index	19/09/22	CI
Optipharm.CO.,LTD(KOSDAQ:A153710) added to S&P Global BMI Index	21/09/20	CI
GenoFocus, Inc. to Enter into Co-Development Agreement with Eight Organizations for COVID-19	03/06/20	CI
Optipharm Co., Ltd. has completed an IPO in the amount of KRW 29.4589 billion.	22/10/18	CI
Optipharm Co., Ltd. has filed an IPO.	01/06/18	CI

Optipharm.CO.,LTD is a Korea-based company mainly engaged in the production and sale of veterinary drugs. The Company operates its business through two segments. The Sale Business segment is involved in the provision of livestock disease appraisal services, animal drug distribution, and the manufacturing and sale of feed additives. The New Business segment is engaged in research and development of heterologous organisms, virus like particle (VLP) vaccines, and human diagnostic kits. Heterogeneous organ products include heterologous skin, xenogeneic islets and xenogeneic corneal products, among others. VLP vaccines include VLP based animal combined vaccines and human papillomavirus (HPV) vaccines for the human body, among others. Human body diagnostic kits include human breast cancer and cervical cancer diagnostic reagents, among others. The Company distributes its products within the domestic market and to overseas markets.

Sector

Pharmaceuticals

Calendar

08/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Veterinary Drugs

	1st Jan change	Capi.
OPTIPHARM.CO.,LTD	-2.42%	74.6M
ZOETIS INC.	-11.87%	79.26B
ELANCO ANIMAL HEALTH INCORPORATED	+14.06%	8.39B
BLUESTAR ADISSEO COMPANY	+28.00%	3.74B
VIRBAC	-1.39%	3.27B
VIMIAN GROUP AB	+21.28%	1.69B
JINYU BIO-TECHNOLOGY CO., LTD.	-3.25%	1.56B
CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD.	-18.63%	1.29B
VETOQUINOL SA	-1.17%	1.28B
WUHAN KEQIAN BIOLOGY CO.,LTD	-6.77%	1.14B